Free Trial

Prima BioMed (IMMP) News Today

Prima BioMed logo
$0.44 -0.01 (-1.93%)
As of 03:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Why Is Prima BioMed Down Today?

Prima BioMed Ltd. (NASDAQ: IMMP) is under pressure today after a wave of securities-class-action and investor-rights notices dominated the news flow. The headlines repeatedly reference a lawsuit alleging investor harm tied to purchases made between March 24, 2025 and March 12, 2026, along with a July 6, 2026 lead-plaintiff deadline. This kind of legal overhang can weigh on sentiment because it raises the risk of additional costs, uncertainty, and potential reputational damage.

In short, IMMP is likely trading lower mainly because of the sustained legal headline risk rather than any new business or clinical update.

Posted 1h agoAI Generated. May Contain Errors.

IMMP Latest News

Get Prima BioMed News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMMP and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMMP Media Mentions By Week

IMMP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMMP
News Sentiment

0.14

0.82

Average
Medical
News Sentiment

IMMP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMMP Articles
This Week

16

3

IMMP Articles
Average Week

Get the Latest News and Ratings for IMMP and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Prima BioMed and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:IMMP) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners